BusinessLeading Medical Organizations Update Guideline for Molecular Testing and Targeted Therapies in Lung CancerBy Nasdaq OMXJan 23, 2018, 7:15 PM UTC
BusinessEarth Science Tech, Inc. President Commits to Donating 50,000 of his Personal Shares to Become the First Contributor to Earth Science FoundationBy Nasdaq OMXJan 18, 2018, 1:01 PM UTC
BusinessCommunity Oncology Alliance Strongly Supports 340B HELP ACTBy Nasdaq OMXJan 17, 2018, 3:17 PM UTC
BusinessPrecipio Appoints New Sales VP to Manage Diagnostics Sales ExpansionBy Nasdaq OMXJan 16, 2018, 1:27 PM UTC
BusinessYale Study Demonstrates Four-Fold Superiority of Academic Level Diagnostic AccuracyBy Nasdaq OMXJan 10, 2018, 1:28 PM UTC
BusinessRadioMedix and AREVA Med announce initiation of Phase 1 clinical trial of AlphaMedix(TM), a Targeted Alpha Therapy for patients with neuroendocrine tumorsBy Nasdaq OMXJan 10, 2018, 10:00 AM UTC
BusinessAdaptimmune Announces Positive Safety Data from Pilot Studies with MAGE-A10 SPEAR T-cells and First Patient to Receive 1 billion Target Cell DoseBy Nasdaq OMXJan 8, 2018, 1:00 PM UTC
